<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0018881"><a href="http://purl.obolibrary.org/obo/MONDO_0018881">MONDO:0018881</a></h3>
<p><strong>Label:</strong> myelodysplastic syndrome</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0019454">MONDO:0019454</a> (refractory anemia with excess blasts), <a href="http://purl.obolibrary.org/obo/MONDO_0019453">MONDO:0019453</a> (refractory cytopenia with multilineage dysplasia), <a href="http://purl.obolibrary.org/obo/MONDO_0013667">MONDO:0013667</a> (myelodysplastic syndrome),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_86839">Orphanet:86839</a>, <a href="http://www.orpha.net/ORDO/Orphanet_86836">Orphanet:86836</a>, <a href="http://www.orpha.net/ORDO/Orphanet_52688">Orphanet:52688</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614286">OMIM:614286</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0002863">HP:0002863</a> (Myelodysplasia) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0002863">HP:0002863</a> (Myelodysplasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system))) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0002863">HP:0002863</a> (Myelodysplasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system))) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002863">HP:0002863</a> (Myelodysplasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system))) 47.86%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002863">HP:0002863</a> (Myelodysplasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0010987">HP:0010987</a> (Abnormality of cellular immune system))) 37.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002863">HP:0002863</a> (Myelodysplasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0001881">HP:0001881</a> (Abnormality of leukocytes))) 37.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) 32.91%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0002863">HP:0002863</a> (Myelodysplasia) 31.40%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) 29.17%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002863">HP:0002863</a> (Myelodysplasia) 25.41%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) and <a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 23.16%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) and <a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) 21.95%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001428">HP:0001428</a> (Somatic mutation) 21.78%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) 18.39%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 14.99%</li>
</ul>
</body>
</html>
